The rapid integration of artificial intelligence (AI) into healthcare is not a distant prospect—it’s happening now.
Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $58.6, along ...
Many people, are looking for ways to lose weight, especially after pregnancy. With the rise of weight-loss drugs, the big question remains—are they safe, and what do ...
RxTechExam and the Pennsylvania Pharmacists Association announced a strategic partnership. Roche’s $8 billion InterMune acquisition has been handed to a specialty pharmaceutical company, Cayman ...
Pliant Therapeutics shares were up 23% to $3.34 after the company said an independent Data Safety Monitoring Board is allowing it to begin the assembly of an outside expert panel to review unblinded ...
COEP Venture Group aims to identify, invest in, and support high-potential startups shaping the future of automation, intelligent systems, and AI-driven enterprise solutions. By providing capital, ...
Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...
Arizona’s Family Investigates found providers high on the job, two of them prescribing hundreds of opioids. Most of them are ...
Nuvation Bio Inc., a pharmaceutical company focused on cancer treatment with a market capitalization of $769 million, announced the departure of Dr. Jerry Wang, CEO of subsidiary AnHeart Therapeutics, ...
Pennington Biomedical Research Center researchers have recently published a piece in the Journal of Medical Internet Research ...
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results